Manufacturer:
Teva
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
phone:
844-248-7949
Approved Indication:
- treatment of thrombocytopenia in adult and pediatric patients 6 years and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy and who are at an increased risk for bleeding
- treatment of thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation of interferon-based therapy
- treatment of adult patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy
Conditions:
- Immune Thrombocytopenia
- Aplastic Anemia
Therapeutic Area:
- Oncology